0001415889-24-015316.txt : 20240604
0001415889-24-015316.hdr.sgml : 20240604
20240604160008
ACCESSION NUMBER: 0001415889-24-015316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LILLY ENDOWMENT INC
CENTRAL INDEX KEY: 0000316011
ORGANIZATION NAME:
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 241017764
BUSINESS ADDRESS:
STREET 1: 2801 NORTH MERIDIAN STREET
CITY: INDIANANAPOLIS
STATE: IN
ZIP: 46208
BUSINESS PHONE: 3179245471
MAIL ADDRESS:
STREET 1: 2801 NORTH MERIDIAN ST
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
form4-06042024_040604.xml
X0508
4
2024-06-03
0000059478
ELI LILLY & Co
LLY
0000316011
LILLY ENDOWMENT INC
2801 NORTH MERIDIAN STREET
INDIANAPOLIS
IN
46208-0068
false
false
true
false
0
Common Stock
2024-06-03
4
S
0
3582
822.071
D
98398022
D
Common Stock
2024-06-03
4
S
0
5570
823.712
D
98392452
D
Common Stock
2024-06-03
4
S
0
2801
824.782
D
98389651
D
Common Stock
2024-06-03
4
S
0
5313
825.778
D
98384338
D
Common Stock
2024-06-03
4
S
0
8505
826.852
D
98375833
D
Common Stock
2024-06-03
4
S
0
17251
827.761
D
98358582
D
Common Stock
2024-06-03
4
S
0
29045
828.896
D
98329537
D
Common Stock
2024-06-03
4
S
0
40708
829.756
D
98288829
D
Common Stock
2024-06-03
4
S
0
29541
830.806
D
98259288
D
Common Stock
2024-06-03
4
S
0
27500
831.826
D
98231788
D
Common Stock
2024-06-03
4
S
0
12813
832.715
D
98218975
D
Common Stock
2024-06-03
4
S
0
4700
833.738
D
98214275
D
Common Stock
2024-06-03
4
S
0
1500
834.813
D
98212775
D
Common Stock
2024-06-03
4
S
0
774
835.861
D
98212001
D
Common Stock
2024-06-03
4
S
0
900
837.16
D
98211101
D
Common Stock
2024-06-03
4
S
0
2291
837.996
D
98208810
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $822.00 to $822.78, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), and (16) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $823.30 to $824.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $824.30 to $825.29, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $825.30 to $826.25, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $826.31 to $827.305, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $827.31 to $828.295, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $828.33 to $829.32, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $829.33 to $830.32, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $830.33 to $831.315, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $831.35 to $832.33, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $832.36 to $833.285, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $833.36 to $834.17, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $834.42 to $835.37, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $835.65 to $836.12, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $836.675 to $837.66, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $837.695 to $838.21, inclusive.
/s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc.
2024-06-04